Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 3
1977 2
1978 6
1979 4
1980 2
1981 1
1982 1
1983 1
1984 3
1986 6
1987 3
1988 4
1989 1
1990 4
1991 7
1992 3
1993 1
1994 1
1995 1
1996 5
1997 2
1998 2
1999 3
2000 2
2001 2
2002 7
2003 7
2004 11
2005 7
2006 6
2007 5
2008 4
2009 6
2010 5
2011 4
2012 4
2013 3
2014 2
2015 7
2016 2
2017 3
2018 3
2019 4
2021 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma.
Kewalramani T, Zelenetz AD, Nimer SD, Portlock C, Straus D, Noy A, O'Connor O, Filippa DA, Teruya-Feldstein J, Gencarelli A, Qin J, Waxman A, Yahalom J, Moskowitz CH. Kewalramani T, et al. Among authors: portlock c. Blood. 2004 May 15;103(10):3684-8. doi: 10.1182/blood-2003-11-3911. Epub 2004 Jan 22. Blood. 2004. PMID: 14739217 Free article. Clinical Trial.
Hodgkin's disease.
Portlock CS. Portlock CS. Med Clin North Am. 1984 May;68(3):729-40. doi: 10.1016/s0025-7125(16)31125-7. Med Clin North Am. 1984. PMID: 6205232 Review.
Review.
Portlock CS. Portlock CS. Clin Adv Hematol Oncol. 2004 Dec;2(12):820. Clin Adv Hematol Oncol. 2004. PMID: 16166959 No abstract available.
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.
Borchmann S, Joffe E, Moskowitz CH, Zelenetz AD, Noy A, Portlock CS, Gerecitano JF, Batlevi CL, Caron PC, Drullinsky P, Hamilton A, Hamlin PA Jr, Horwitz SM, Kumar A, Matasar MJ, Moskowitz AJ, Owens CN, Palomba ML, Younes A, Straus DJ. Borchmann S, et al. Among authors: portlock cs. Blood. 2019 May 16;133(20):2121-2129. doi: 10.1182/blood-2018-10-877761. Epub 2019 Feb 15. Blood. 2019. PMID: 30770396 Free PMC article.
Autologous bone marrow transplantation.
Gulati SC, Yahalom J, Portlock C. Gulati SC, et al. Among authors: portlock c. Curr Probl Cancer. 1991 Jan-Feb;15(1):1-57. Curr Probl Cancer. 1991. PMID: 2001627 Review.
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP.
Bantilan KS, Smith AN, Maurer MJ, Teruya-Feldstein J, Matasar MJ, Moskowitz AJ, Straus DJ, Noy A, Palomba ML, Horwitz SM, Hamlin PA, Portlock CS, Cerhan JR, Habermann TM, Salles GA, Nowakowski GS, Moskowitz CH, Zelenetz AD. Bantilan KS, et al. Among authors: portlock cs. Blood Adv. 2024 May 14;8(9):2172-2181. doi: 10.1182/bloodadvances.2023011408. Blood Adv. 2024. PMID: 38271621 Free PMC article.
Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
Joffe E, Leyfman Y, Drill E, Rajeeve S, Zelenetz AD, Palomba ML, Moskowitz CH, Portlock C, Noy A, Horwitz SM, Gerecitano JF, Moskowitz A, Hamlin P, Matasar MJ, Kumar A, Batlevi CL, Younes A, Straus DJ. Joffe E, et al. Among authors: portlock c. Blood Adv. 2021 Jan 26;5(2):345-351. doi: 10.1182/bloodadvances.2020003213. Blood Adv. 2021. PMID: 33496731 Free PMC article.
155 results